- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Tumor protein p53 (TP53) is a sequence-specific transcription factor that functions as a central tumor suppressor controlling DNA damage responses, apoptosis, and genomic stability. The p53 Antibody Microarray Specificity Validated Clone TP53/2092R is a recombinant rabbit monoclonal antibody developed for detection of p53 protein and distinguished by protein microarray-based validation confirming highly selective recognition of TP53.
TP53 antibody reagents are widely used in cancer research because p53 is one of the most frequently altered proteins in human tumors. The TP53 gene, located on chromosome 17p13.1, encodes Tumor protein p53, also known as Cellular tumor antigen p53. This transcription factor contains several functional regions including an N-terminal transcriptional activation domain, a central DNA-binding domain responsible for sequence-specific gene regulation, a tetramerization domain required for formation of active transcription complexes, and a regulatory C-terminal region that modulates DNA binding and protein stability.
The defining characteristic of the p53 Antibody Microarray Specificity Validated clone TP53/2092R is the use of high-density human protein microarray screening to evaluate antibody specificity. In this approach, thousands of full-length human proteins are immobilized on a single array and probed with the antibody, allowing direct assessment of cross-reactivity across the human proteome. This Microarray Specificity Validated strategy provides strong evidence that clone TP53/2092R selectively recognizes Tumor protein p53 while minimizing off-target interactions.
Protein microarray validation is particularly important for transcription factors such as p53 that participate in complex signaling pathways and share structural features with other regulatory proteins. The p53 Antibody Microarray Specificity Validated reagent therefore provides researchers with increased confidence in the specificity of TP53 detection when studying tumor suppressor signaling, DNA damage response pathways, and cancer-associated cellular stress mechanisms.
By combining recombinant monoclonal antibody technology with Microarray Specificity Validated screening, the p53 Antibody Microarray Specificity Validated clone TP53/2092R offers a reagent designed for highly specific detection of p53 protein. This approach supports research investigating TP53 pathway activation, transcriptional regulation of growth control genes, and molecular mechanisms underlying genomic stability and tumor suppression.
The stated application concentrations are suggested starting points. Titration of the p53 Antibody Microarray Specificity Validated Clone TP53/2092R may be required due to differences in protocols and secondary/substrate sensitivity.
1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.
Recombinant human protein was used as the immunogen for this p53 Antibody Microarray Specificity Validated Clone TP53/2092R.
Store the recombinant p53 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
TP53 antibody, Tumor protein p53 antibody, Cellular tumor antigen p53 antibody, p53 tumor suppressor antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.